Thus, clarifying the precise molecular mechanism of KRAS in the development of pancreatic cancer is a pivotal way to conquer it, and the inhibition of KRAS downstream targets is considered an effective strategy[11]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.